First Comparison of Amulet and Watchman FLX LAA Closure Devices

$ 17.50

4.7
(228)
In stock
Description

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Abbott Vascular

Diagnostic and Interventional Cardiology

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Diagnostic and Interventional Cardiology

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Diagnostic and Interventional Cardiology

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Diagnostic and Interventional Cardiology

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Structural Heart Occluders

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Diagnostic and Interventional Cardiology